These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24606555)

  • 1. Comment on clinical development of candidate HIV vaccines: different problems for different vaccines.
    McMichael A; Dorrell L
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):331-2. PubMed ID: 24606555
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary on Shapiro: clinical development of candidate HIV vaccines: different problems for different vaccines.
    Hope TJ; Betts MR
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):330. PubMed ID: 24620907
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV research may be right on target for potential vaccine.
    Rees J
    Expert Rev Vaccines; 2013 Jul; 12(7):719. PubMed ID: 23885816
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV vaccine development: strategies for preclinical and clinical investigation.
    Shapiro SZ
    AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1401-6. PubMed ID: 23379343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical development of candidate HIV vaccines: different problems for different vaccines.
    Shapiro SZ
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):325-9. PubMed ID: 24168166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broadly neutralizing antibodies and vaccine design against HIV-1 infection.
    Wang Q; Zhang L
    Front Med; 2020 Feb; 14(1):30-42. PubMed ID: 31858368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based analysis of HIV-1 antibodies reveals structural constraints that may inform vaccine design.
    Tobin SC
    AIDS; 2015 Sep; 29(15):N13. PubMed ID: 26237101
    [No Abstract]   [Full Text] [Related]  

  • 8. Natural infection as a blueprint for rational HIV vaccine design.
    van Haaren MM; van den Kerkhof TL; van Gils MJ
    Hum Vaccin Immunother; 2017 Jan; 13(1):229-236. PubMed ID: 27649455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current world literature.
    Curr Opin HIV AIDS; 2012 Jan; 7(1):86-95. PubMed ID: 22156801
    [No Abstract]   [Full Text] [Related]  

  • 10. The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses.
    Ringel O; Vieillard V; Debré P; Eichler J; Büning H; Dietrich U
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29662026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in HIV vaccines inducing mucosal immune responses.
    Pavot V; Rochereau N; Lawrence P; Girard MP; Genin C; Verrier B; Paul S
    AIDS; 2014 Jul; 28(12):1701-18. PubMed ID: 25009956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cautious optimism for HIV vaccine science.
    Gray GE; Michael NL
    Curr Opin HIV AIDS; 2013 Sep; 8(5):367-8. PubMed ID: 23924996
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel approaches in preclinical HIV vaccine research.
    Safrit JT; Koff WC
    Curr Opin HIV AIDS; 2016 Nov; 11(6):601-606. PubMed ID: 27636502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lynn Morris: the continuing quest for an HIV vaccine.
    Kirby T
    Lancet Infect Dis; 2017 Feb; 17(2):150. PubMed ID: 28134120
    [No Abstract]   [Full Text] [Related]  

  • 15. Designing synthetic vaccines for HIV.
    Fernández-Tejada A; Haynes BF; Danishefsky SJ
    Expert Rev Vaccines; 2015 Jun; 14(6):815-31. PubMed ID: 25824661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Shot in the Arm for HIV Prevention? Recent Successes and Critical Thresholds.
    Hope TJ; Marrazzo JM
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1055-9. PubMed ID: 26486613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of the Cent Gardes HIV Vaccines Conference, Part 2: The cellular immune response. Fondation Mérieux Conference Center, Veyrier-du-Lac, France, 25-27 October 2015.
    Girard MP; Le-Grand R; Picot V; Longuet C; Nabel GJ
    Vaccine; 2016 Nov; 34(46):5470-5473. PubMed ID: 27692524
    [No Abstract]   [Full Text] [Related]  

  • 18. Hope for HIV control in southern Africa: The continued quest for a vaccine.
    Bekker LG; Gray GE
    PLoS Med; 2017 Feb; 14(2):e1002241. PubMed ID: 28245236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV vaccine: Can it be developed in the 21st century?
    Verma R; Khanna P; Chawla S; Dhankar M
    Hum Vaccin Immunother; 2016; 12(1):222-4. PubMed ID: 26212081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New directions for HIV vaccine development from animal models.
    McChesney MB; Miller CJ
    Curr Opin HIV AIDS; 2013 Sep; 8(5):376-81. PubMed ID: 23836045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.